Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists-Reference-Cited by-同舟云学术

Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists

Published:2019 Issue:12 Volume:10 Page:2078-2088
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Mastromarino Margherita¹²³⁴,Kirpotina Liliya N.⁵⁶⁷⁸,Schepetkin Igor A.⁵⁶⁷⁸,Quinn Mark T.⁵⁶⁷⁸^ORCID,Lacivita Enza¹²³⁴^ORCID,Leopoldo Marcello¹²³⁴^ORCID

Affiliation:

1. Dipartimento di Farmacia – Scienze del Farmaco

2. Università degli Studi di Bari Aldo Moro

3. 70125 Bari

4. Italy

5. Department of Microbiology and Immunology

6. Montana State University

7. Bozeman

8. USA

Abstract

Aurantiamide is a useful scaffold to develop promising FPR1 antagonists capable of inhibiting neutrophil chemotaxis.

Funder

National Institutes of Health

National Institute of Food and Agriculture

Montana Agricultural Experiment Station

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MD/C9MD00336C

Reference29 articles.

1. Regulation of inflammation by members of the formyl-peptide receptor family

2. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

3. The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition

4. N-formylmethionyl peptides as chemoattractants for leucocytes.

5. Pleiotropic roles of formyl peptide receptors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models;European Journal of Medicinal Chemistry;2023-12

2. Pd-Catalyzed Remote δ-C(sp2)–H Functionalization in Phenylalaninol: Expanding the Library of Phenylalaninols;Synthesis;2023-08-02

3. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome;Frontiers in Molecular Biosciences;2022-05-25